摘要
炎症是一种有害的身体刺激本能反应,是由白细胞增加了运动(特别是粒细胞)从血液进入组织损伤。它是愈合伤口和感染所需的。尽管他们在微生物杀灭中不可或缺的作用,但是炎症反应也可能导致疾病的宿主,如花粉热,动脉粥样硬化,类风湿性关节炎。在炎症过程中释放的酶和氧化物种可能会导致导致炎症综合征的宿主组织的损害。髓过氧化物酶(MPO)的作用,在炎症反应是有据可查的。它有助于杀死病原体,但它也牵连在几个炎症性疾病,如帕金森氏病,阿尔茨海默氏病和动脉粥样硬化。因此,这种酶已引起了科学家们的关注,并已成为药物设计的一个目标。在过去的十年中,几个可逆和不可逆的髓过氧化物酶抑制剂被鉴定为很高的强效抑制剂如氟烷基吲哚,芳香异羟肟酸,硫代黄嘌呤和苯甲酸酰肼衍生物。在本文中,我们试图说明髓过氧化物酶髓过氧化物酶抑制剂和突出自己的结构活性关系(SAR)。在本文中,我们还讨论了最有效的化合物的抑制作用的机制.
关键词: 髓过氧化物酶,可逆性抑制剂,不可逆抑制剂,药物设计,对接,构效关系。
Current Medicinal Chemistry
Title:Myeloperoxidase as a Target for the Treatment of Inflammatory Syndromes: Mechanisms and Structure Activity Relationships of Inhibitors
Volume: 23 Issue: 35
Author(s): Jalal Soubhye, Iyas Aldib, Cédric Delporte, Martine Prévost, François Dufrasne, Pierre Van Antwerpen
Affiliation:
关键词: 髓过氧化物酶,可逆性抑制剂,不可逆抑制剂,药物设计,对接,构效关系。
摘要: Inflammation is an initial response of the body to a harmful stimuli and it is achieved by the increased movement of leukocytes (especially granulocytes) from blood into injured tissues. It is required for healing wounds and infections. Despite their indispensable role in microbial killing, the inflammation reactions may also cause diseases to a host such as hay fever, atherosclerosis, and rheumatoid arthritis. The enzymes and oxidizing species released during the inflammatory process can cause damages to the host tissues which lead to inflammatory syndromes. The role of myeloperoxidase (MPO) in the inflammatory reactions is well documented. It contributes in killing the pathogens but it is also implicated in several inflammatory syndromes such as Parkinson's disease, Alzheimer’s disease and atherosclerosis. Thus, this enzyme has attracted more attention of the scientists and it has become a target for drug designing. In the last decade, several reversible and irreversible MPO inhibitors were identified as very high potent inhibitors such as fluoroalkylindole, aromatic hydroxamic acid, thioxanthine and benzoic acid hydrazide derivatives. In this review, we tried to illustrate the MPO inhibitors and highlight their structure activity relationship (SAR). In this paper we also discussed the mechanism of the inhibitory effect of the most potent compounds.
Export Options
About this article
Cite this article as:
Jalal Soubhye, Iyas Aldib, Cédric Delporte, Martine Prévost, François Dufrasne, Pierre Van Antwerpen , Myeloperoxidase as a Target for the Treatment of Inflammatory Syndromes: Mechanisms and Structure Activity Relationships of Inhibitors, Current Medicinal Chemistry 2016; 23 (35) . https://dx.doi.org/10.2174/0929867323666160607111806
DOI https://dx.doi.org/10.2174/0929867323666160607111806 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Multidisciplinary Atrial Fibrillation Clinic
Current Cardiology Reviews Peroxisome Proliferator-Activated Receptors and the Control of Fatty Acid Oxidation in Cardiac Hypertrophy
Mini-Reviews in Medicinal Chemistry Lipid Lowering Drugs and Gallstones: A Therapeutic Option?
Current Pharmaceutical Design Recent Applications of Peanut Phytoalexins
Recent Patents on Food, Nutrition & Agriculture Biomarkers of Oxidative Stress and the Relationship to Cigarette Smoking
Mini-Reviews in Organic Chemistry Statin Therapy for Native and Peri-Interventional Coronary Heart Disease
Current Molecular Medicine Understanding Heterogeneity in Supplementation Effects of Selenium in Men: A Study of Stratification Variables and Human Genetics in a Prospective Sample from New Zealand
Current Pharmacogenomics and Personalized Medicine Identification and Investigation of Chalcone Derivatives as Calcium Channel Blockers: Pharmacophore Modeling, Docking Studies, In vitro Screening, and 3D-QSAR Analysis
Current Computer-Aided Drug Design Long-Term Treatment With Raltegravir is Associated with Lower Triglycerides and Platelets Count in the Older HIV+ Population: Results from the Ral-Age Study
Current HIV Research Synthesis and Cytotoxic Activity of 4-Aryl-4H-chromeno[4,3-d] [1,2,3] selenadiazoles
Letters in Drug Design & Discovery Annexin A5 Imaging: An Academic Research – Clinical Trials and Theses
Current Molecular Imaging (Discontinued) Editorial [Hot Topic: Perspectives of New Antihypertensive Drugs (Executive Editor: Ji-Guang Wang)]
Current Pharmaceutical Design Asymmetric Dimethylarginine: A Possible Link between Vascular Disease and Dementia
Current Alzheimer Research Cancer Chemoprevention by Targeting the Epigenome
Current Drug Targets Plasma Protein Binding in Drug Discovery and Development
Combinatorial Chemistry & High Throughput Screening Endothelial Dysfunction Induced by Cadmium and Mercury and its Relationship to Hypertension
Current Hypertension Reviews Histone Deacetylase Inhibitors and Colorectal Cancer: what is new?
Anti-Cancer Agents in Medicinal Chemistry Biomarkers of Lung Tissue Remodeling in Pulmonary Diseases: Implications for Clinical Practice and Research
Current Respiratory Medicine Reviews Obesity and Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Rosuvastatin and Diabetes: When the Evidences Talk
Cardiovascular & Hematological Agents in Medicinal Chemistry